<DOC>
	<DOCNO>NCT02758431</DOCNO>
	<brief_summary>This study plan learn heart vascular age men . In men get old , testosterone level fall normal range young men . Also , men get old cardiovascular health worsens . This lead high blood pressure heart disease . In study want find cause cardiovascular health worsen old men . Also want find happen testosterone level lower short time . Specifically , want see reduction cardiovascular health old men low testosterone level damage mitochondrion . Mitochondria main power supply cell body . The result study help understand cardiovascular health decline old men low testosterone level compare young men old men higher testosterone level . Knowing information help develop therapy prevent heart disease men .</brief_summary>
	<brief_title>Cardiovascular Outcomes Low Testosterone</brief_title>
	<detailed_description>Cardiovascular ( CV ) age , feature large artery stiffening , endothelial dysfunction , impaired leave ventricular ( LV ) diastolic function , major risk factor development cardiovascular disease ( CVD ) . Male age associate gradual variable decline serum testosterone ( T ) low T associate accelerated CV aging . The purpose research determine key functional mechanism underlie accelerated CV age old men low T. The overall hypothesis mitochondrial dysfunction oxidative stress mechanism underlie apparent accelerate CV age old men low T. To test hypothesis Aim 1 use cross-sectional comparison young old men normal T ( ≥400 ng/dl ) , old men chronically low T ( &lt; 300 ng/dl ) . To well isolate effect low T factor change age chronic low T , Aim 2 expand cross-sectional comparison assess measure CV function , oxidative stress burden mitochondrial function old men normal T randomization short-term ( 28 ) gonadal suppression ( gonadotropin release hormone antagonist , GnRHant ) + placebo ( PL ) , GnRHant+T alone , GnRHant+T+aromatase inhibitor ( AI ) . AI control effect aromatization T estradiol ( E2 ) , thereby isolate T effect suppress E2 , potent modulator CV function . The result research provide new mechanistic insight process mediate impairment CV function cellular systemic level old men low T. These study lead good understanding independent role T age-related change CV function mechanism action , help guide future sex-specific therapy prevention CVD .</detailed_description>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Hormone Antagonists</mesh_term>
	<mesh_term>Anastrozole</mesh_term>
	<mesh_term>Aromatase Inhibitors</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<criteria>1 . Men age 1840 year 5070 year 2 . Chronically low testosterone group testosterone concentration &lt; 250 ng/dl , young old normal testosterone group testosterone level 4001000 ng/dl 3 . No use sex hormone least 1 year 4 . Body mass index &lt; 35 kg/m2 5 . Nonsmokers 6 . Resting blood pressure &lt; 140/90 mmHg 7 . Fasting plasma glucose &lt; 126 mg/dL 8 . Healthy , determine medical history , physical examination , standard blood chemistry ( chemistry panel , complete blood clot circulate thyroid level ) grade exercise stress test monitoring blood pressure electrocardiogram ( ECG ) 9 . Sedentary recreationally active ( &lt; 3 days/wk vigorous aerobic exercise ) 10 . No use medication might influence cardiovascular function include antihypertensive , lipid lower medication , corticosteroid 11 . Total cholesterol &lt; 240 mg/dl low density lipoproteincholesterol &lt; 160 mg/dl 12 . No use vitamin supplement antiinflammatory medication , willing stop 1 month prior throughout study . 1 . Contraindications : 1 . Gonadotropin release hormone ( GnRH ) antagonist 2 . Testosterone gel aromatase inhibitor include hypersensitivity Acyline , Androgel® , Arimidex® 3 . Extrinsic peptide hormone , mannitol , GnRH GnRH analogs 2 . History active prostate breast cancer sex hormonedependent neoplasms 3 . Preexisting active cardiac , renal hepatic disease 4 . History stomach ulcer bleed 5 . History epilepsy seizure disorder 6 . Diabetes 7 . Active infection 8 . Disease affect nervous system 9 . Abnormal rest ECG Additionally , men participate gonadal suppression intervention study understand randomly assign study group involve either GnRH antagonist plus testosterone gel plus placebo tablet ( 33 % chance ) , GnRH antagonist plus testosterone gel plus aromatase inhibitor tablet ( 33 % chance ) GnRH antagonist plus placebo gel plus placebo tablet ( 33 % chance ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>testosterone</keyword>
</DOC>